Answers are grounded in this paper and cite their sources.
This prospective, randomized clinical study suggests an immunomodulatory role for the volatile anesthetic sevoflurane in patients undergoing OLV for thoracic surgery with significant reduction of inflammatory mediators and a significantly better clinical outcome (defined by postoperative adverse events) during sevoflurane anesthesia.
No takes yet. Share an insight, caveat, or question.
Conno et al. (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: